Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Fate Therapeutics, Inc. Income Statement Banner

Fate Therapeutics, Inc. Income Statement

FATE Stock Analysis

Page title

Section title

Breakdown
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Total Revenue
0.0002.431M4.402M4.106M4.740M10.680M31.434M55.846M96.300M63.533M
Cost of Revenue
16.435M19.861M26.452M34.358M56.024M87.770M125.623M5.850M13.758M18.282M
Gross Profit
-16.435m-17.430m-22.050m-30.252m-51.284m-77.090m-94.189m49.996M82.542M45.251M
Operating Expense
24.904M30.213M36.365M46.231M71.832M111.407M159.519M272.840M404.686M222.862M
Operating Income
-24.904m-27.782m-31.963m-42.125m-67.092m-100.727m-128.085m-216.994m-308.386m-177.611m
Other Income Expense
0.0000.0000.0000.0000.0000.0000.0000.00020.823M9.882M
Total Other Income Expense
-432.000k-2.210m-1.499m-118.000k494.000K2.578M-45.302m4.843M26.665M16.683M
Pretax Income
-25.883m-29.992m-33.462m-42.952m-66.598m-98.149m-173.387m-212.151m-281.721m-160.928m
Tax Provision
53.000K-677.000k-743.000k297.000K2.190M-441.000k-3.087m-5.850m-26.665m18.114M
Net Income
-25.883m-29.992m-33.462m-42.952m-66.598m-97.708m-170.300m-206.301m-255.056m-160.928m
Basic EPS
-1.270-1.180-1.050-1.020-1.190-1.430-2.070-2.180-2.630-1.640
Diluted EPS
-1.270-1.180-1.050-1.020-1.190-1.430-2.070-2.180-2.630-1.640
Basic Average Shares
20.452M25.484M31.754M41.982M56.196M68.191M82.385M94.747M96.826M98.411M
Diluted Average Shares
20.452M25.484M31.754M41.982M56.196M68.191M82.385M94.747M96.826M98.411M
Total Expenses
24.904M30.213M36.365M46.231M71.832M111.407M159.519M272.840M404.686M241.144M
Interest Income
2.000K10.000K138.000K559.000K2.190M4.330M2.400M1.309M5.842M17.186M
Interest Expense
549.000K2.220M1.637M1.268M1.696M1.752M0.0000.0005.842M0.000
EBITDA
-24.902m-27.772m-31.825m-41.566m-64.902m-96.397m-125.685m-215.685m-308.386m-159.329m
Depreciation & Amortization
496.000K687.000K881.000K971.000K1.204M2.193M3.087M5.850M13.758M18.282M